Credentis develops and commercializes a remineralisation system for the treatment of small caries lesions. The Swiss company has entered into a partnership with DentaQuest to test and promote Curodont Repair Fluoride Plus and other Curolox products in the North American Market, enabling better pre-cavity treatment and prevention for US consumers.

Through this collaboration, DentaQuest will be the only US dental benefits company introducing these innovative products through DentaQuest’s national caries management partners and through its own preventive oral health centers. DentaQuest is an oral health care company managing dental and vision benefits for more than 27 million Americans and providing direct care to patients through its network of more than 85 oral health centers in five states.

“In addition to giving Americans access to therapies that can promote the healing of teeth and reverse the progression of tooth decay before cavities form, we are excited to work with credentis to assess the preventive benefits of their existing products and help develop new ones that could help millions more live cavity free,” said Kirill Zaydenman, Vice President of Innovation for DentaQuest. “We believe credentis’ unique preventive technology has the potential to not only improve consumer health and enhance patient experience, but also lower the cost of care.”

“The partnership with DentaQuest provides an exceptional opportunity to demonstrate the benefit of credentis’ Curolox products and establish them in US dental practice.” said Dominik Lysek, CEO and founder of credentis ag.